Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Toxicology, pharmacokinetics, and immunogenicity studies of CCR4-IL2 bispecific immunotoxin in rats and minipigs

European Journal of Pharmacology(2024)10.1016/j.ejphar.2024.176408Source: DataRank Database

Toxicology, pharmacokinetics, and immunogenicity studies of CCR4-IL2 bispecific immunotoxin in rats and minipigs is a research paper published in European Journal of Pharmacology (2024). On theSindex it has a DataRank of 0.165. It has been cited 2 times.

N/A

0.165DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.30)OA: greenTopics (52)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.165

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (15)

Rashmi Ramakrishna,Yong Wang ORCID,Yue Qiu ORCID,Jihong Ma,Danielle Mintzlaff

Live enrichment

PubMed:38367684 PMC:PMC10939744 OpenAlex:https://openalex.org/W4391849972

NCI

Grant: 1R42CA261547-01

NHLBI

Grant: U01HL152405

State of Colorado

Grant: CTGG1 2022-2206

NCI NIH HHS

Grant: R42 CA261547

National Institutes of Health

FWCI

0.30

Citation Percentile

0.5%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10939744/pdf/nihms-1969989.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0014299924000967?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0014299924000967?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10939744

Fields of Study

Toxin Mechanisms and ImmunotoxinsCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies ResearchMiceRatsHumansAnimalsSwineImmunotoxinsSwine, MiniatureInterleukin-2Leukocytes, MononuclearReceptors, CCR4Antibodies, MonoclonalMice, SCIDAntineoplastic Agents

MeSH Terms

AnimalsAntibodies, MonoclonalImmunotoxinsAntineoplastic AgentsHumansInterleukin-2Leukocytes, MononuclearSwineSwine, MiniatureMice, SCIDMiceRatsReceptors, CCR4

Keywords

CCR4MedicinePharmacokineticsImmunogenicityPharmacologyImmunotoxinCutaneous T-cell lymphomaPeripheral blood mononuclear cellImmunologyT cellMycosis fungoidesInternal medicineLymphomaAntibodyMonoclonal antibodyImmune systemChemistryIn vitroChemokineCutaneous T Cell LymphomaToxicology StudyCcr4-il2 Bispecific ImmunotoxinImmunotoxin Pharmacokinetics

Sustainable Development Goals

SDG 0: Good health and well-being